CONSHOHOCKEN, Pa., May 8, 2025 /PRNewswire/ -- The GBS | CIDP Foundation International is commemorating Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy Awareness Month ...
A 12-year-old held an art festival Saturday to benefit a rare disorder that his mother has. Jace Ricciuti held the event downtown for chronic inflammatory demyelinating polyneuropathy, also known as ...
Want to take a walk or roll to help a global charity find new strides in getting its message out? Then join the “Walk & Roll” for GBS-CIDP, at 10 a.m. Saturday for 1 mile across Conway’s Riverfront ...
Chronic inflammatory demyelinating polyradiculoneuropathy is a rare autoimmune-related condition that affects nerve signaling ...
The FDA on March 16 approved CSL Behring’s drug Hizentra to treat chronic inflammatory demyelinating polyneuropathy. Hizentra is the first subcutaneous immunoglobulin approved to treat CIDP, a rare ...
KING OF PRUSSIA, Pa., Dec. 9, 2019 /PRNewswire/ -- Global biotherapeutics leader CSL Behring announced today that Hizentra received orphan-drug exclusivity from the U.S. Food and Drug Administration ...
CONSHOHOCKEN, Pa., May 8, 2025 /PRNewswire/ -- The GBS | CIDP Foundation International is commemorating Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy Awareness Month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results